Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.18.7575

Five miRNAs as Novel Diagnostic Biomarker Candidates for Primary Nasopharyngeal Carcinoma  

Tang, Jin-Feng (Clinical Research Center, Guangdong Medical College)
Yu, Zhong-Hua (Department of Oncology, Affiliated Hospital of Guangdong Medical College)
Liu, Tie (Department of Hematology, the Second Affiliated Hospital, Medical School of Xi'an Jiaotong University)
Lin, Zi-Ying (Clinical Research Center, Guangdong Medical College)
Wang, Ya-Hong (Clinical Research Center, Guangdong Medical College)
Yang, La-Wei (Clinical Research Center, Guangdong Medical College)
He, Hui-Juan (Clinical Research Center, Guangdong Medical College)
Cao, Jun (Department of Pathology, Affiliated Hospital of Guangdong Medical College)
Huang, Hai-Li (Clinical Research Center, Guangdong Medical College)
Liu, Gang (Clinical Research Center, Guangdong Medical College)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.18, 2014 , pp. 7575-7581 More about this Journal
Abstract
MicroRNAs (miRNAs) play an essential role in the development and progression of nasopharyngeal carcinomas (NPC). Despite advances in the field of cancer molecular biology and biomarker discovery, the development of clinically validated biomarkers for primary NPC has remained elusive. In this study, we investigated the expression and clinical significance of miRNAs as novel primary NPC diagnostic biomarkers. We used an array containing 2, 500 miRNAs to identify 22 significant miRNAs, and these candidate miRNAs were validated using 67 fresh NPC and 25 normal control tissues via quantitative real-time PCR (qRT-PCR). Expression and correlation analyses were performed with various statistical approaches, in addition to logistic regression and receiver operating characteristic curve analyses to evaluate diagnostic efficacy. qRT-PCR revealed five differentially expressed miRNAs (miR-93-5p, miR-135b-5p, miR-205-5p and miR-183-5p) in NPC tissue samples relative to control samples (p<0.05), with miR-135b-5p and miR-205-5p being of significant diagnostic value (p<0.01). Moreover, comparison of NPC patient clinicopathologic data revealed a negative correlation between miR-93-5p and miR-183-5p expression levels and lymph node status (p<0.05). These findings display an altered expression of many miRNAs in NPC tissues, thus providing information pertinent to pathophysiological and diagnostic research. Ultimately, miR-135b-5p and miR-205-5p may be implicated as novel NPC candidate biomarkers, while miR-93-5p, miR-650 and miR-183-5p may find application as relevant clinical pathology and diagnostic candidate biomarkers.
Keywords
miRNAs; nasopharyngeal carcinomas; qRT-PCR; biomarkers;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Abbasi A N, Zahid S, Bhurgri Y, et al (2011). Nasopharyngeal carcinoma - an update of treatment and acute radiation induced reactions from a tertiary-care hospital in Pakistan. Asian Pac J Cancer Prev, 12, 735-8.
2 Cao P, Zhou L, Zhang J, et al (2013). Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma. Head Neck, 35, 720-8.   DOI   ScienceOn
3 Chen H C, Chen G H, Chen Y H, et al (2009). MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer, 100, 1002-11.   DOI   ScienceOn
4 Fu X, Tian J, Zhang L, et al (2012). Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett, 586, 1279-86.   DOI   ScienceOn
5 Jiang M, Zhang P, Hu G, et al (2013). Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients. Mol Cell Biochem, 383, 67-75.   DOI   ScienceOn
6 Guo X-G, Xia Y (2013). The interleukin-18 promoter-607C> A polymorphism contributes to nasopharyngeal carcinoma Risk: Evidence from a Meta-analysis Including 1, 886 Subjects. Asian Pac J Cancer Prev, 14, 7577-81.   DOI   ScienceOn
7 Iizasa H, Wulff BE, Alla NR, et al (2010). Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J Biol Chem, 285, 33358-70.   DOI   ScienceOn
8 Iorio MV, Croce CM (2012). microRNA involvement in human cancer. Carcinogenesis, 33, 1126-33.   DOI
9 Kozubek J, Ma Z, Fleming E, et al (2013). In-depth characterization of microRNA transcriptome in melanoma. PLoS One, 8, 72699.   DOI
10 Larne O, Martens-Uzunova E, Hagman Z, et al (2013). miQ--a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int J Cancer, 132, 2867-75.   DOI   ScienceOn
11 Lauvrak S U, Munthe E, Kresse S H, et al (2013). Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer, 109, 2228-36.   DOI   ScienceOn
12 Lebanony D, Benjamin H, Gilad S, et al (2009). Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol, 27, 2030-7.   DOI   ScienceOn
13 Lee N, Xia P, Quivey J M, et al (2002). Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys, 53, 12-22.   DOI   ScienceOn
14 Liu N, Chen N Y, Cui R X, et al (2012). Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol, 13, 633-641.   DOI   ScienceOn
15 Li MY, Liu JQ, Chen DP, et al (2014). Glycididazole sodium combined with radiochemotherapy for locally advanced nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 15, 2641.   과학기술학회마을   DOI   ScienceOn
16 Li T, Chen J X, Fu X P, et al (2011). microRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep, 25, 1353-63.
17 Lin JC, Chiang CF, Wang SW, et al (2014). Significance of Expression of Human METCAM/MUC18 in Nasopharyngeal Carcinomas and Metastatic Lesions. Asian Pac J Cancer Prev, 15, 245-52.   과학기술학회마을   DOI   ScienceOn
18 Liu N, Cui R X, Sun Y, et al (2014). A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma. Int J Cancer, 134, 1359-68.   DOI   ScienceOn
19 Liu N, Tang L L, Sun Y, et al (2013a). MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer Lett, 329, 181-8.   DOI   ScienceOn
20 Liu X, Luo H N, Tian W D, et al (2013b). Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma. Cancer Biol Ther, 14.
21 Long J, Wang Y, Wang W, et al (2010). Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biological Chemis, 285, 23457-65.   DOI   ScienceOn
22 Lu J, Getz G, Miska E A, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.   DOI   ScienceOn
23 Qiu J, Cosmopoulos K, Pegtel M, et al (2011). A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog, 7, 1002193.   DOI
24 Luo W R, Gao F, Li S Y, et al (2012). Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase 1 in nasopharyngeal carcinoma. Histopathology, 61, 1072-81.   DOI   ScienceOn
25 Ma F, Zhang J, Zhong L, et al (2014). Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/beta-catenin signaling. Gene, 535, 191-7.   DOI   ScienceOn
26 Marquitz A R, Raab-Traub N (2012). The role of miRNAs and EBV BARTs in NPC. Semin Cancer Biol, 22, 166-72.   DOI   ScienceOn
27 Raab-Traub N, Flynn K, Pearson G, et al (1987). The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer, 39, 25-29.   DOI
28 Sarver A L, Li L, Subramanian S (2010). MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res, 70, 9570-80.   DOI
29 Schetter A J, Harris C C (2011). Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol, 38, 734-72.   DOI   ScienceOn
30 Sun XJ, Liu H, Zhang P, et al (2013). miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells. Asian Pac J Cancer Prev, 14, 5533-37.   과학기술학회마을   DOI   ScienceOn
31 Tsuchiyama K, Ito H, Taga M, et al (2013). Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate, 73, 827-34.   DOI   ScienceOn
32 Xie L, Yang Z, Li G, et al (2013). Genome-wide identification of bone metastasis-related microRNAs in lung adenocarcinoma by high-throughput sequencing. PLoS One, 8, 61212.   DOI
33 Wolf H, Zur Hausen H, Klein G, et al (1975). Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol, 161, 15-21.   DOI
34 Xi Y, Nakajima G, Gavin E, et al (2007). Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA, 13, 1668-74.   DOI   ScienceOn
35 Xiao Z G, Deng Z S, Zhang Y D, et al (2013). Clinical significance of microRNA-93 downregulation in human colon cancer. Eur J Gastroenterol Hepatol, 25, 296-01.   DOI
36 Yang H J, Huang T J, Yang C F, et al (2013). Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells. Virol J, 10, 314.   DOI   ScienceOn
37 Yang I P, Tsai H L, Hou M F, et al (2012). MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. Carcinogenesis, 33, 1522-30.   DOI   ScienceOn
38 Zheng G, Wang H, Zhang X, et al (2013). Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS One, 8, 83025.   DOI   ScienceOn
39 Zhi F, Cao X, Xie X, et al (2013). Identification of circulating MicroRNAs as potential biomarkers for detecting acute myeloid leukemia. PloS one, 8, 56718.   DOI
40 Shanmugaratnam K, 1991, Histological typing of tumours of the upper respiratory tract and ear. World Health Organization International Histological Classification of Tumours. Springer-Verlag, Berlin, p. 32-34 pp.
41 Lo A K, Dawson C W, Jin D Y, et al (2012). The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J Pathol, 227, 392-03.   DOI   ScienceOn